HemaCell
PrivateLast Round
Series B
Jun 2, 2026
Total Funding Raised
$57.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
HemaCell is a biotechnology company that develops stem cell-based therapeutics for the regeneration of blood cells to treat various diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HemaCell Comparables
Compare HemaCell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HemostOD SA | 83% | |
| Megakaryon Corporation | 80% | |
| Stellular Bio | 77% |
HemaCell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 2, 2026 | ||||
| VC Round | Jan 8, 2025 | ||||
| Series A | Dec 19, 2023 | ||||
| VC Round | May 27, 2022 | ||||
| Pre Seed | Feb 25, 2022 | ||||
Seed | Oct 9, 2021 |
HemaCell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zhongbo Juli | Series A |
| 招银国际金融有限公司 | Pre Seed |
| Wedo Venture Partners | Series B, Pre Seed, VC Round, Seed |
| Northern Light Venture Capital | Pre Seed, VC Round |
| Country Garden Ventures Capital | Pre Seed, VC Round |
| Luxin Venture Capital Group | VC Round |
| Founder Hesheng Investment Co., Ltd. | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2026
$42M round with CDH Investments and others
- Jan 8, 2025
Completed a VC Round fundraise.
HemaCell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about HemaCell's valuation, stock price, and market status.
Is HemaCell a public or private company?
HemaCell is a private company.
What is the current stock price of HemaCell?
HemaCell is a private company with no public stock price. No recent secondary market data is available.
How much is HemaCell worth (valuation)?
Valuation information for HemaCell is not publicly available.
Can I buy HemaCell stock?
HemaCell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was HemaCell's last funding round?
Funding round information for HemaCell is not publicly available.
Who are the main investors in HemaCell?
Investor information for HemaCell is not publicly disclosed.
Will HemaCell IPO soon?
No public IPO plans have been announced for HemaCell.
How can I track HemaCell secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor HemaCell's secondary market activity and sign up for updates.